The fluorescent immunocytochemical diagnostics of precancerous diseases and cancer of the oral mucosa.

Q4 Health Professions
A. Pursanova, L. N. Kazarina, I. Kruglova, S. Zinovev, O. Utkin, E. Filatova
{"title":"The fluorescent immunocytochemical diagnostics of precancerous diseases and cancer of the oral mucosa.","authors":"A. Pursanova, L. N. Kazarina, I. Kruglova, S. Zinovev, O. Utkin, E. Filatova","doi":"10.51620/0869-2084-2022-67-4-219-226","DOIUrl":null,"url":null,"abstract":"Purpose of the study improving the diagnosis of precancerous diseases and cancer of the oral mucosa using fluorescent immunocytochemical studies by direct immunofluorescence. A clinical laboratory examination of 111 patients was carried out: 46 patients with squamous cell carcinoma of the oral mucosa, 35 people with precancerous lesions (17 leukoplakia, 18 - oral lichen planus) and 30 healthy people. All patients underwent a traditional cytological examination and an additional immunocytochemical examination by direct immunofluorescence, the expression levels of tumor markers P53, P16 and Ki67 were determined. The data were compared with the results of histological analysis. As a result of the study, it was revealed that in patients with cancer, the expression of oncomarker P53 was four times higher than in patients with precancerous pathology. In 6.52% of cases, co-expression of markers Ki67 and P16 was found. Thus, the advantages of fluorescent immunocytochemical diagnostics were the absence of invasive traumatic intake of the biomaterial in the patient, reduction in the timing of obtaining the result, high sensitivity, and the possibility of remote evaluation of the results. Therefore, that increases the accessibility of the method, and the possibility of using this method for a screening study of population.","PeriodicalId":52451,"journal":{"name":"Klinichescheskaya Laboratornaya Diagnostika","volume":"1 1","pages":"219-226"},"PeriodicalIF":0.0000,"publicationDate":"2022-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klinichescheskaya Laboratornaya Diagnostika","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.51620/0869-2084-2022-67-4-219-226","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Health Professions","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose of the study improving the diagnosis of precancerous diseases and cancer of the oral mucosa using fluorescent immunocytochemical studies by direct immunofluorescence. A clinical laboratory examination of 111 patients was carried out: 46 patients with squamous cell carcinoma of the oral mucosa, 35 people with precancerous lesions (17 leukoplakia, 18 - oral lichen planus) and 30 healthy people. All patients underwent a traditional cytological examination and an additional immunocytochemical examination by direct immunofluorescence, the expression levels of tumor markers P53, P16 and Ki67 were determined. The data were compared with the results of histological analysis. As a result of the study, it was revealed that in patients with cancer, the expression of oncomarker P53 was four times higher than in patients with precancerous pathology. In 6.52% of cases, co-expression of markers Ki67 and P16 was found. Thus, the advantages of fluorescent immunocytochemical diagnostics were the absence of invasive traumatic intake of the biomaterial in the patient, reduction in the timing of obtaining the result, high sensitivity, and the possibility of remote evaluation of the results. Therefore, that increases the accessibility of the method, and the possibility of using this method for a screening study of population.
口腔黏膜癌前病变和癌的荧光免疫细胞化学诊断。
目的探讨直接免疫荧光荧光免疫细胞化学对口腔黏膜癌前病变和癌的诊断价值。本文对111例患者进行了临床实验室检查,其中口腔黏膜鳞状细胞癌46例,癌前病变35例(白斑17例,口腔扁平苔藓18例),健康人30例。所有患者均接受传统细胞学检查和直接免疫荧光免疫细胞化学检查,检测肿瘤标志物P53、P16和Ki67的表达水平。将数据与组织学分析结果进行比较。研究结果显示,在癌症患者中,癌标记物P53的表达比癌前病理患者高4倍。6.52%的病例共表达Ki67和P16标记物。因此,荧光免疫细胞化学诊断的优点是患者体内没有创伤性生物材料的侵入性摄入,减少了获得结果的时间,灵敏度高,并且可以远程评估结果。因此,这增加了该方法的可及性,以及将该方法用于人群筛选研究的可能性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Klinichescheskaya Laboratornaya Diagnostika
Klinichescheskaya Laboratornaya Diagnostika Health Professions-Medical Laboratory Technology
CiteScore
0.90
自引率
0.00%
发文量
110
期刊介绍: The journal deals with theoretical and practical problems of clinical laboratory diagnosis, publishes editorial articles, reviews of literature, original articles, short reports, discussions, book reviews, current events, materials which may assist the practitioners, methods of laboratory investigations used in medicine, materials on the results of practical application of new methods of investigation in the following fields of clinical laboratory diagnosis: hematology, cytology, coagulation, biochemistry, immunology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信